Concepedia

Publication | Open Access

An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)

147

Citations

11

References

2017

Year

Abstract

RECAP provides long-term follow-up and safety data for pirfenidone that were consistent with the known profile, with no new safety signals observed.

References

YearCitations

Page 1